Andrea Markl Corse, M.D.

Headshot of Andrea Markl Corse
  • Co-Director, Myasthenia Gravis Center
  • Associate Professor of Neurology



Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment


Johns Hopkins Outpatient Center (now called Levi Watkins, Jr., M.D., Outpatient Center)

Appointment Phone: 410-614-4278
601 N. Caroline St.
Baltimore, MD 21287 map

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-614-4278
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287 map


Dr. Corse earned her medical degree at the University of Kansas School of Medicine and came to Johns Hopkins as an intern. She completed her neurology residency training at Johns Hopkins serving as chief resident, followed by a two-year combined basic and clinical research fellowship in neuromuscular disease.

Currently an Associate Professor of Neurology and Neurological Surgery, Dr. Corse directs the Neuromuscular Pathology Laboratory, which uses muscle and nerve biopsies to diagnose conditions such as autoimmune disorders and a range of myopathies. She provides clinical expertise in the management of myasthenia gravis (MG), myositis and amyotrophic lateral sclerosis (ALS).Over the past decade she has worked on several national and international ALS clinical trials. more


  • Co-Director, Myasthenia Gravis Center
  • Associate Professor of Neurology
  • Associate Professor of Neurosurgery

Departments / Divisions

Centers & Institutes



  • MD; University of Kansas (1987)


  • Neurology; Johns Hopkins University School of Medicine (1991)


  • Neurology; Johns Hopkins University School of Medicine (1993)

Board Certifications

  • American Board of Psychiatry And Neurology (Neurology) (1992)

Research & Publications

Selected Publications

View all on PubMed

Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial.

Meininger V, Pradat PF, Corse A, Al-Sarraj S, Rix Brooks B, Caress JB, Cudkowicz M, Kolb SJ, Lange D, Leigh PN, Meyer T, Milleri S, Morrison KE, Orrell RW, Peters G, Rothstein JD, Shefner J, Lavrov A, Williams N, Overend P, Price J, Bates S, Bullman J, Krull D, Berges A, Abila B, Meno-Tetang G, Wurthner J.

PLoS One. 2014 May 19;9(5):e97803. doi: 10.1371/journal.pone.0097803. eCollection 2014.

PMID: 24841795


The co-existence of myasthenia gravis in patients with myositis: a case series.

Paik JJ, Corse AM, Mammen AL.

Semin Arthritis Rheum. 2014 Jun;43(6):792-6. doi: 10.1016/j.semarthrit.2013.12.005. Epub 2013 Dec 18.

PMID: 24412588


Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease.

Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith AM, Jacques TS, Lundberg IE, Minetti C, Nennesmo I, Rushing EJ, Sallum AM, Sewry C, Pilkington CA, Holton JL, Wedderburn LR; the UK Juvenile Dermatomyositis Research Group.

Ann Rheum Dis. 2013 Sep 24. doi: 10.1136/annrheumdis-2013-203396. [Epub ahead of print]

PMID: 24064003


A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.

Howard JF Jr, Barohn RJ, Cutter GR, Freimer M, Juel VC, Mozaffar T, Mellion ML, Benatar MG, Farrugia ME, Wang JJ, Malhotra SS, Kissel JT; MG Study Group.

Muscle Nerve. 2013 Jul;48(1):76-84. doi: 10.1002/mus.23839. Epub 2013 Apr 30.

PMID: 23512355


Expanding the spectrum of monoclonal light chain deposition disease in muscle.

Ostrow LW, Corse AM, Morrison BM, Huff CA, Carrino JA, Hoke A, Mammen AL.

Muscle Nerve. 2012 May;45(5):755-61. doi: 10.1002/mus.23287.

PMID: 22499107

Activities & Honors


  • Top Doctor 2017, Baltimore Magazine, 2017 - 2017

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button